Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis

Gupta, A. K., Stec, N., Bamimore, M. A., Foley, K. A., Shear, N. H. and Piguet, V. 2020. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis. Journal of the European Academy of Dermatology and Venereology 34 (3) , pp. 580-588. 10.1111/jdv.16101
Item availability restricted.

[img] PDF - Accepted Post-Print Version
Restricted to Repository staff only until 20 November 2020 due to copyright restrictions.

Download (531kB)

Abstract

Background Onychomycosis is a chronic, fungal infection of the nails. Complete cure remains challenging, but oral antifungal medications have been successful in managing the fungus for a significant proportion of patients. Treatment with these drugs can be continuous or intermittent, albeit the evidence on their relative efficacies remains unclear. Objective To determine the relative effectiveness and safety of pulse versus continuous administration, of three common oral therapies for dermatophyte onychomycosis, by conducting multiple‐treatment meta‐analysis. Methods This systematic review and network meta‐analysis compared the efficacy (as per mycological cure) and adverse event rates of three oral antifungal medications in the treatment of dermatophyte toenail onychomycosis, namely terbinafine, itraconazole and fluconazole. A total of 30 studies were included in the systematic review, while 22 were included in the network meta‐analysis. Results The likelihood of mycological cure was not significantly different between continuous and pulse regimens for each of terbinafine and itraconazole. Use of continuous terbinafine for 24 weeks – but not 12 weeks – was significantly more likely to result in mycological cure than continuous itraconazole for 12 weeks or weekly fluconazole for 9–12 months. Rank probabilities demonstrated that 24‐week continuous treatment of terbinafine was the most effective. There were no significant differences in the likelihood of adverse events between any continuous and pulse regimens of terbinafine, itraconazole and fluconazole. Drug treatments were similar to placebo in terms of their likelihood of producing adverse events. Conclusion More knowledge about the fungal life cycle and drugs’ pharmacokinetics in nail and plasma could further explain the relative efficacy and safety of the pulse and continuous treatment regimens. Our results indicate that in the treatment of dermatophyte toenail onychomycosis, the continuous and pulse regimens for terbinafine and itraconazole have similar efficacies and rates of adverse events.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Wiley
ISSN: 0926-9959
Date of First Compliant Deposit: 3 February 2020
Date of Acceptance: 11 November 2019
Last Modified: 12 Mar 2020 17:02
URI: http://orca-mwe.cf.ac.uk/id/eprint/129271

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics